THOMAS, MCNERNEY & PARTNERS ANNOUNCES PRATIK SHAH, PH.D. AS NEW VENTURE PARTNER IN SAN FRANCISCO OFFICE

SAN FRANCISCO, November 8, 2004 – Thomas, McNerney & Partners, LLC, a health care private equity firm that invests in life science and medical technology companies, today announced that Pratik Shah, Ph.D. has joined the firm’s San Francisco office as a venture partner. Pratik was most recently the chief business officer and co-founder of Kalypsys, a San Diego-based biopharmaceutical company.

“Pratik joins Thomas, McNerney & Partners with a wealth of knowledge in the life sciences and significant hands-on operational and financial experience,” said Karen Boezi, managing partner. “With his diverse skill set, we are confident that he will be a key addition to our team, helping us identify the most rewarding investments and adding value as the companies progress through their development.”

At Kalypsys, Pratik was responsible for the overall strategy, business development and operations of the company. He also oversaw raising more than $130 million in equity financings and corporate deals. Prior to co-founding Kalypsys, Pratik was at McKinsey & Company where he focused on biotechnology and venture capital projects. Pratik’s McKinsey engagements included the spin-off of a new venture from a leading biotechnology company, development of corporate strategies for biopharmaceutical companies and due diligence on M&A and venture investment opportunities. He was formerly co-founder and vice president of operations at NephRx Corporation, a start-up company focused on the discovery of therapeutic proteins for renal disease. Pratik holds a B.S. in Biological Sciences from the University of California at Irvine and both a Ph.D. in Biochemistry & Molecular Biology and an M.B.A. in Finance from the University of Chicago.

“I have been very impressed by Thomas, McNerney & Partners’ active involvement and leadership in their portfolio companies,” said Pratik. “The firm has a proven ability to identify good investment opportunities and to position companies to generate significant value post-investment.”

About Thomas, McNerney & Partners
With offices in New York, Minneapolis and San Francisco, Thomas, McNerney & Partners, LLC, is a health care private equity firm that invests in life science and medical technology companies. The firm's partners have successfully funded companies at all stages of their development, having collectively invested over $500 million in more than 40 entities. With a multi-stage investment approach, Thomas, McNerney & Partners provides seed and early stage funding to help entrepreneurs launch companies, as well as growth capital to emerging companies for furthering clinical development or for expansion of product commercialization. The firm is also involved in spinning-out products and divisions from major medical device and pharmaceutical companies to form new entities, consolidating companies through roll-up strategies and participating in recapitalizations. Thomas, McNerney & Partners is targeting investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors as well as other areas utilizing medical technology innovation. For more information, please visit http://www.tm-partners.com.